Skip to main content

Table 3 Maternal outcomes

From: The efficacy and safety of intrathecal dexmedetomidine for parturients undergoing cesarean section: a double-blind randomized controlled trial

 

Group B (n = 100)

Group FB (n = 100)

Group DB (n = 100)

P-Value

Shivering, n (%)

35 (35)

18 (82) *

3 (97) *#

< 0.001

Hypotension, n (%)

28 (28)

25 (25)

33 (33)

0.450

Dose of ephedrine (mg)

2.8 ± 3.9

2.1 ± 3.6

1.5 ± 3.0

0.029

Nausea and/or vomiting, n (%)

11 (11)

17 (17)

14 (14)

0.474

Sufentanil consumption (μg)

106.0 ± 9.2

105.5 ± 7.7

105.0 ± 7.8

0.681

  1. Notes: Data are presented as n (%) or mean ± SD; Group B = bupivacaine group; Group FB = bupivacaine and fentanyl group; Group DB = bupivacaine and dexmedetomidine group
  2. *P < 0.017 Group DB or Group FB vs Group B; #P < 0.017 Group DB vs Group FB
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us